HIGHLIGHTS
SUMMARY
The 2022 BCLC has recognized liver transplantation (LT) as one of main objectives, widening the indications to a subgroup of BCLC-B patients, in case of successful downstaging by TACE. According to the improvements and evidence arising in HCC management, an extension of resection criteria has recently been advocated, acknowledging that selected BCLC-B patients may benefit more from surgery rather than other locoregional therapies. The aim of this study was to evaluate the safety and efficacy of surgical resection (SR) in BCLC stage B patients versus the standard treatment according to BCLC guidelines . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.